Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension
収録刊行物
-
- The Journal of Heart and Lung Transplantation
-
The Journal of Heart and Lung Transplantation 39 (12), 1389-1397, 2020-12
Elsevier BV